newsfilter
← Earnings
Earnings Releases·

Rapid Micro Biosystems — Third Quarter 2026 Earnings Summary

Rapid Micro Biosystems reported third-quarter 2026 total revenue of $9.5 million, reflecting a 22% increase from the same period in 2025. The company achieved a record gross margin of 25%, driven by a 19 percentage point rise in product margins and a 14 percentage point increase in service margins. Net loss for the quarter was $11.3 million, while non-GAAP adjusted EBITDA loss narrowed to $7.9 million from $9.4 million in the prior year. On November 16, 2026, the company announced a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany, leading to the withdrawal of its full-year 2026 guidance and a delay in filing its Form 10-Q.

Company
RAPID MICRO BIOSYSTEMS INC
Sector
Healthcare
Industry
Medical Devices